IRISanRaf

CATURANO, ALFREDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.249
SA - Sud America 1.196
NA - Nord America 1.191
EU - Europa 176
AF - Africa 59
OC - Oceania 12
Totale 5.883
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 2.509
US - Stati Uniti d'America 1.131
BR - Brasile 925
VN - Vietnam 468
AR - Argentina 114
CN - Cina 74
EC - Ecuador 58
ID - Indonesia 53
HK - Hong Kong 47
IT - Italia 41
MX - Messico 37
CO - Colombia 31
DE - Germania 30
BD - Bangladesh 28
ZA - Sudafrica 28
PY - Paraguay 22
RU - Federazione Russa 18
CA - Canada 17
CL - Cile 16
GB - Regno Unito 16
IN - India 14
PL - Polonia 14
PE - Perù 12
UA - Ucraina 12
IQ - Iraq 10
VE - Venezuela 9
IE - Irlanda 8
AT - Austria 7
AU - Australia 7
EG - Egitto 7
PK - Pakistan 7
MA - Marocco 5
NZ - Nuova Zelanda 5
UY - Uruguay 5
AL - Albania 4
JP - Giappone 4
NL - Olanda 4
NP - Nepal 4
TN - Tunisia 4
AM - Armenia 3
AO - Angola 3
BO - Bolivia 3
CR - Costa Rica 3
KZ - Kazakistan 3
TW - Taiwan 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
BW - Botswana 2
BY - Bielorussia 2
DZ - Algeria 2
EE - Estonia 2
FI - Finlandia 2
FR - Francia 2
KR - Corea 2
PT - Portogallo 2
SA - Arabia Saudita 2
SN - Senegal 2
TR - Turchia 2
BJ - Benin 1
BN - Brunei Darussalam 1
CD - Congo 1
CG - Congo 1
CH - Svizzera 1
ES - Italia 1
GH - Ghana 1
GR - Grecia 1
GY - Guiana 1
HU - Ungheria 1
IL - Israele 1
IR - Iran 1
IS - Islanda 1
JO - Giordania 1
KW - Kuwait 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LY - Libia 1
MK - Macedonia 1
MU - Mauritius 1
MY - Malesia 1
NI - Nicaragua 1
QA - Qatar 1
RS - Serbia 1
SE - Svezia 1
SV - El Salvador 1
TH - Thailandia 1
Totale 5.883
Salva come PNG Salva come JPEG
Città #
Dallas 946
Singapore 176
Ho Chi Minh City 172
Hanoi 93
São Paulo 79
Hong Kong 45
Ashburn 43
Beijing 31
Rio de Janeiro 26
Mexico City 22
Haiphong 20
Quito 20
Guayaquil 19
Brasília 16
Munich 16
Manaus 15
Thái Bình 15
Biên Hòa 13
Bogotá 13
Guarulhos 13
Hải Dương 13
Johannesburg 13
Curitiba 12
Da Nang 12
Can Tho 11
New York 11
Porto Alegre 11
Asunción 10
Belo Horizonte 10
Campinas 10
Jakarta 10
Los Angeles 10
Ninh Bình 10
Duque de Caxias 9
Frankfurt am Main 9
Buenos Aires 8
Bắc Giang 8
Bắc Ninh 8
Caxias do Sul 8
Fortaleza 8
Goiânia 8
Quảng Ngãi 8
Salvador 8
Santiago 8
Santo André 8
Warsaw 8
Bauru 7
Brooklyn 7
Chicago 7
Dhaka 7
Joinville 7
Lima 7
Maricá 7
Naples 7
Petrópolis 7
Recife 7
São José 7
Thái Nguyên 7
Cabo Frio 6
Cape Town 6
Dublin 6
Ha Long 6
Hortolândia 6
Montreal 6
Sorocaba 6
Sumaré 6
Suzano 6
Caruaru 5
Chennai 5
Council Bluffs 5
Juiz de Fora 5
Ribeirão Preto 5
San Francisco 5
Santa Clara 5
São Bernardo do Campo 5
Aracaju 4
Bagé 4
Bandung 4
Blumenau 4
Boardman 4
Boston 4
Boydton 4
Bình Dương 4
Campos dos Goytacazes 4
Canoas 4
Catanduva 4
Ciudad del Este 4
Guarujá 4
Jacareí 4
Macaé 4
Montevideo 4
Natal 4
Osasco 4
Piracicaba 4
Viamão 4
Vienna 4
Vila Velha 4
Vinh 4
Arapiraca 3
Auckland 3
Totale 2.318
Salva come PNG Salva come JPEG
Nome #
Advances in Nanomedicine for Precision Insulin Delivery 231
Nonalcoholic fatty liver disease and type 2 diabetes: pathophysiological mechanisms shared between the two faces of the same coin 228
Impact of Acute Kidney Injury on the COVID-19 In-Hospital Mortality in Octogenarian Patients: Insights from the COVOCA Study 223
The impact of incidental hepatocellular carcinoma in liver transplantation: A growing concern 221
Advances in the Insulin–Heart Axis: Current Therapies and Future Directions 220
Precision Medicine in Type 2 Diabetes Mellitus: Utility and Limitations 220
Coronary Microvascular Dysfunction in Diabetes Mellitus: Pathogenetic Mechanisms and Potential Therapeutic Options 219
Impact of gliflozins on cardiac remodeling in patients with type 2 diabetes mellitus & reduced ejection fraction heart failure: A pilot prospective study. GLISCAR study 219
Diabetic Gastroparesis: Navigating Pathophysiology and Nutritional Interventions 218
Can metformin exert as an active drug on endothelial dysfunction in diabetic subjects? 211
Insulin–Heart Axis: Bridging Physiology to Insulin Resistance 190
SGLT2 Inhibitors and GLP-1 Receptor Agonists in PAD: A State-of-the-Art Review 183
Metabolic Dysfunction-Associated Steatotic Liver Disease in Klinefelter Syndrome: High Prevalence Uncovers an Unmet Need 173
Cardiovascular and Metabolic Disease: New Treatment and Future Directions—The 3rd Edition 156
Impact of Gliflozins on Right Heart Remodeling in Italian Patients with Type 2 Diabetes and Heart Failure: Results from the GLISCAR Real-World Study 147
Liver Involvement in Patients with Systemic Sclerosis: Role of Transient Elastography in the Assessment of Hepatic Fibrosis and Steatosis 117
Risk Stratification For and Use of DOAC Therapies for Stroke Prevention in Patient with Atrial Fibrillation 60
Oxidative Stress in Type 2 Diabetes: Impacts from Pathogenesis to Lifestyle Modifications 57
Alcohol Consumption and Liver Metabolism in the Era of MASLD: Integrating Nutritional and Pathophysiological Insights 55
Bridging ADHD and Metabolic Disorders: Insights into Shared Mechanisms and Clinical Implications 54
A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease 46
An Overview of the Cardiorenal Protective Mechanisms of SGLT2 Inhibitors 45
Advancements in Cardiovascular and Antidiabetic Drug Therapy 41
Antioxidant and Antidiabetic Potential of the Antarctic Lichen Gondwania regalis Ethanolic Extract: Metabolomic Profile and In Vitro and In Silico Evaluation 41
Aspirin in a diabetic retinopathy setting: Insights from NO BLIND study 41
Albuminuria-Lowering Effect of Dapagliflozin, Eplerenone, and Their Combination in Patients with Chronic Kidney Disease: A Randomized Crossover Clinical Trial 38
ULTRASOUND TIPS IN THE LUNG CANCER DIAGNOSIS: A PILOT STUDY 38
Optimizing Body Composition During Weight Loss: The Role of Amino Acid Supplementation 36
Cardiovascular and Metabolic Disease: New Treatment and Future Directions 35
Oral Anticoagulation for Atrial Fibrillation in Octogenarians Across the Renal Function Spectrum 35
Peripheral Neuropathy in Diabetes Mellitus: Pathogenetic Mechanisms and Diagnostic Options 35
Lack of effect on in-hospital mortality of drugs used during COVID-19 pandemic: Findings of the retrospective multicenter COVOCA study 35
Atrial fibrillation and stroke. A review on the use of vitamin K antagonists and novel oral anticoagulants 35
Role of albuminuria in detecting cardio-renal risk and outcome in diabetic subjects 34
The Importance of Telemedicine during COVID-19 Pandemic: A Focus on Diabetic Retinopathy 34
Assessment of the Effectiveness of Ticagrelor Preloading in Mitigating Periprocedural Myocardial Injury Among Non-ST Elevation Myocardial Infarction Patients Opting for an Early Invasive Approach 34
The prognostic role of interatrial block among COVID-19 patients hospitalized in medicine wards 34
Association between Renal Function at Admission and COVID-19 in-Hospital Mortality in Southern Italy: Findings from the Prospective Multicenter Italian COVOCA Study 34
Relationship between albuminuric CKD and diabetic retinopathy in a real-world setting of type 2 diabetes: Findings from No blind study 34
Assessment of Response and Safety of Bulevirtide Treatment in Patients with Chronic Delta Virus Infection: The ARISTOTLE Pilot Observational Study 34
The Intestinal Thread of Fate: How the Microbiota Shapes the Story of Liver Disease 34
Sex-difference of multifactorial intervention on cardiovascular and mortality risk in DKD: post-hoc analysis of a randomised clinical trial 34
Cardiovascular and Metabolic Disease: New Treatment and Future Directions 2.0 34
Long-term clinical outcomes of patients with drug-induced type 1 Brugada electrocardiographic pattern: A nationwide cohort registry study 33
Anti-Inflammatory and Anticancer Effects of Anticoagulant Therapy in Patients with Malignancy 33
Neurophysiological assessment of peripheral neuropathy through whole plantar nerve conduction in type 2 diabetes mellitus and healthy control subjects 33
Application and internal validation of lung ultrasound score in COVID-19 setting: The ECOVITA observational study 33
Bivalirudin Use for Primary Percutaneous Coronary Intervention on Long-Term Mortality 33
Multidrug-Resistant Infections and Metabolic Syndrome: An Overlooked Bidirectional Relationship 32
Optimizing Anticoagulation Management in Atrial Fibrillation: Beyond the Guidelines. How and for Whom? 32
Remdesivir treatment and clinical outcome in non-severe hospitalized COVID-19 patients: a propensity score matching multicenter Italian hospital experience 32
Does a strict glycemic control during acute coronary syndrome play a cardioprotective effect? Pathophysiology and clinical evidence 32
Advances in Pharmacological Approaches for Managing Hypercholesterolemia: A Comprehensive Overview of Novel Treatments 32
Cardiorenal Impact of SGLT-2 Inhibitors: A Conceptual Revolution in The Management of Type 2 Diabetes, Heart Failure and Chronic Kidney Disease 32
Insulin resistance and cancer: molecular links and clinical perspectives 32
Right ventricular electrocardiographic abnormalities among hospitalized COVID-19 patients: Simple marker of worst clinical outcome 31
Reply to Saeed et al. Comment on “Rinaldi et al. Assessment of Response and Safety of Bulevirtide Treatment in Patients with Chronic Delta Virus Infection: The ARISTOTLE Pilot Observational Study. Viruses 2025, 17, 251” 31
The Dual Burden: Exploring Cardiovascular Complications in Chronic Kidney Disease 31
An Update on Betrixaban, the Challenging Anticoagulant Agent for Extended Venous Thromboembolism Prophylaxis 31
Impact of sglt2 inhibitors on heart failure: From pathophysiology to clinical effects 31
HCC and molecular targeting therapies: Back to the future 31
Electrophysiological Study Prognostic Value and Long-Term Outcome in Drug-Induced Type 1 Brugada Syndrome: The IBRYD Study 31
Warfarin adherence and anticoagulation control in atrial fibrillation patients-a systematic review 31
Editorial on: Canagliflozin Mediates Mitophagy Through the AMPK/PINK1/PARKIN Pathway to Alleviate Isoprenaline-Induced Cardiac Remodeling 30
Predictors of Plasma Levels of Direct Oral Anticoagulants Among Patients with Atrial Fibrillation in Need of Elective Cardiac Procedures 30
Sarcopenic obesity and weight loss-induced muscle mass loss 30
Non-alcoholic fatty liver disease: From pathogenesis to clinical impact 30
Impact of chronic liver disease upon admission on COVID-19 in-hospital mortality: Findings from COVOCA study 30
Left bundle branch pacing and cardiac remodeling in HF patients with type 2 diabetes mellitus: epigenetic pathways and clinical outcomes 30
Comment on: Effect of Vitamin D supplementation in patients with liver cirrhosis having spontaneous bacterial peritonitis: a randomized controlled study 30
Improvement of Global Longitudinal Strain and Myocardial Work in Type 2 Diabetes Patients on Sodium-Glucose Cotransporter 2 Inhibitors Therapy 29
Effects of a Combination of Empagliflozin Plus Metformin vs. Metformin Monotherapy on NAFLD Progression in Type 2 Diabetes: The IMAGIN Pilot Study 29
Metabolic Rewiring of Bacterial Pathogens in Response to Antibiotic Pressure—A Molecular Perspective 29
Impact of direct acting antivirals (DAAs) on cardiovascular events in HCV cohort with pre-diabetes 29
Post-fracture thromboprophylaxis: is it time for a change? 29
The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc analysis of the NID-2 trial 29
Impact of liver fibrosis on COVID-19 in-hospital mortality in Southern Italy 29
Commentary on Antithrombotic Effect of Protopanaxatriol Saponins from Panax notoginseng Using Zebrafish Model 28
Efficacy and durability of multifactorial intervention on mortality and MACEs: a randomized clinical trial in type-2 diabetic kidney disease 28
The Lipid-Lowering Efficacy of a Nutraceutical Combination Including Leucoselect Phytosome, Red Yeast Rice, Policosanol and Folic Acid in Dyslipidaemia Patients: Real-World Insights 28
HAND GRIP STRENGTH EVALUATION IN RHEUMATOLOGIC DISEASES 28
Comment on: Prevalence of micro and macro vascular complications and their risk factors in type 2 diabetes in saudi arabian population: An analysis from shis 28
Comment on: Warfarin adherence and anticoagulation control in atrial fibrillation patients-a systematic review 27
Current Knowledge on the Pathophysiology of Lean/Normal-Weight Type 2 Diabetes 27
Clinical performance of subcutaneous vs. transvenous implantable defibrillator in patients with ischemic cardiomyopathy: data from Monaldi Rhythm Registry 27
New Advances in Cardiovascular Drugs: A Celebration of the 90th Birthday of Professor Akira Endo 26
Mechanisms of non-alcoholic fatty liver disease in the metabolic syndrome. A narrative review 26
Cardiovascular and Metabolic Disease: New Treatments and Future Directions 2.0 26
Subcutaneous versus transvenous implantable cardioverter-defibrillator among drug-induced type-1 ECG pattern Brugada syndrome: a propensity score matching analysis from IBRYD study 26
NerveCheck master to screen patients with type 1 or type 2 diabetes for peripheral and cardiac autonomic neuropathy 25
Rethinking the Diabetes–Cardiovascular Disease Continuum: Toward Integrated Care 24
The Significance of Statin-Associated Muscle Symptoms and Its Impact on Patient Adherence and Outcomes 24
When the dual-chamber pacing system is the optimal choice for Brugada patients in need of implantable cardiac defibrillator 23
Non-alcoholic Fatty Liver Disease (NAFLD), Type 2 Diabetes, and Non-viral Hepatocarcinoma: Pathophysiological Mechanisms and New Therapeutic Strategies 23
Impact of Empagliflozin as add-on to Metformin vs Metformin continuation on MASLD Progression in Type 2 Diabetes: The IMAGIN Study 20
Oxidative Stress and Cardiovascular Complications in Type 2 Diabetes: From Pathophysiology to Lifestyle Modifications 18
Predictive value of Shanghai score system in patients with drug-induced type 1 Brugada electrocardiographic pattern 17
Brugada syndrome and COVID-19 vaccines 15
Polypharmacy and Major Adverse Events in Atrial Fibrillation 13
Clinical Utilization and Performance of Bempedoic Acid in an Italian Real-World Setting: Insight from Campania Region 12
Totale 5.832
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.451
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.451
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/20252.593 0 0 0 0 0 0 4 18 2 227 1.264 1.078
2025/20263.423 192 361 1.381 1.267 222 0 0 0 0 0 0 0
Totale 6.016